SEC Form D · filed December 7, 2021
Saliogen Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Sean Stalfort · Cambridge, MADirectorJoseph Higgins · Cambridge, MAExec · DirectorRaymond Tabibiazar · Cambridge, MAExec · DirectorCraig Gordon · Cambridge, MADirectorSukumar Nagendran · Cambridge, MADirectorTamanna Bembenek, Ph.D · NEW YORK, NYDirectorPatrick Horan · NEW YORK, NYDirectorChris Darland · NEW YORK, NYExec · DirectorCedarview GP, LLC · Woodmere, NYExec · DirectorNicholas Jackson · NEW YORK, NYDirectorDevin Carty · Branford, CTExec · DirectorJason Baumgartner · Branford, CTDirectorYechuan Zhang · London, United KingdomDirectorRichard Skeet · London, United KingdomExec · DirectorMichael P. Brown Ii · Austin, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗